Bath & Body Works, Inc. (NYSE:BBWI) Given Average Recommendation of “Moderate Buy” by Brokerages

Bath & Body Works, Inc. (NYSE:BBWI) has received a consensus rating of “Moderate Buy” from the seventeen research firms that are presently covering the firm, MarketBeat Ratings reports. Six research analysts have rated the stock with a hold rating and eleven have issued a buy rating on the company. The average twelve-month target price among analysts that have updated their coverage on the stock in the last year is $37.1786.

A number of research analysts recently issued reports on the company. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Bath & Body Works in a report on Wednesday, October 8th. Telsey Advisory Group reaffirmed an “outperform” rating and issued a $38.00 price target on shares of Bath & Body Works in a report on Thursday, August 28th. Morgan Stanley cut their price target on Bath & Body Works from $19.00 to $18.00 and set an “overweight” rating for the company in a report on Friday, September 12th. JPMorgan Chase & Co. reaffirmed a “neutral” rating and issued a $26.00 price target on shares of Bath & Body Works in a report on Monday, October 6th. Finally, Wall Street Zen cut Bath & Body Works from a “buy” rating to a “hold” rating in a report on Saturday, August 9th.

Bath & Body Works Stock Performance

Shares of NYSE BBWI opened at $26.37 on Wednesday. The business has a fifty day moving average of $27.65 and a two-hundred day moving average of $29.08. Bath & Body Works has a 52-week low of $24.85 and a 52-week high of $41.87. The stock has a market cap of $5.44 billion, a PE ratio of 7.82, a PEG ratio of 0.89 and a beta of 1.52.

Bath & Body Works (NYSE:BBWI) last released its quarterly earnings results on Thursday, August 28th. The company reported $0.37 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.37. Bath & Body Works had a negative return on equity of 48.43% and a net margin of 9.88%.The business had revenue of $1.55 billion during the quarter, compared to analysts’ expectations of $1.55 billion. During the same period in the previous year, the business posted $0.37 earnings per share. The firm’s revenue for the quarter was down .8% compared to the same quarter last year. Bath & Body Works has set its Q3 2025 guidance at 0.370-0.45 EPS. FY 2025 guidance at 3.350-3.600 EPS. Analysts predict that Bath & Body Works will post 3.3 earnings per share for the current year.

Bath & Body Works Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, September 5th. Investors of record on Friday, August 22nd were given a $0.20 dividend. This represents a $0.80 dividend on an annualized basis and a yield of 3.0%. The ex-dividend date was Friday, August 22nd. Bath & Body Works’s dividend payout ratio (DPR) is presently 23.74%.

Institutional Trading of Bath & Body Works

Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Stonehage Fleming Financial Services Holdings Ltd acquired a new stake in Bath & Body Works in the second quarter worth about $33,000. SVB Wealth LLC acquired a new stake in Bath & Body Works in the first quarter worth about $35,000. Geneos Wealth Management Inc. increased its position in Bath & Body Works by 217.7% in the first quarter. Geneos Wealth Management Inc. now owns 1,169 shares of the company’s stock worth $35,000 after purchasing an additional 801 shares during the period. Parallel Advisors LLC increased its position in Bath & Body Works by 63.3% in the second quarter. Parallel Advisors LLC now owns 1,241 shares of the company’s stock worth $37,000 after purchasing an additional 481 shares during the period. Finally, Golden State Wealth Management LLC increased its position in Bath & Body Works by 94.7% in the first quarter. Golden State Wealth Management LLC now owns 1,320 shares of the company’s stock worth $40,000 after purchasing an additional 642 shares during the period. 95.14% of the stock is currently owned by institutional investors and hedge funds.

About Bath & Body Works

Bath & Body Works, Inc is a specialty retailers and home to America’s Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.